Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Morris

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Immunology|June 14, 2023
Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with LymphomaEkaterina Minskaia, Jesmeen Maimaris, Persephone Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphomaKarl S Peggs, Irfan Kayani, Noha Edwards, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activityKarl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2007
Monoclonal T-cell receptors: new reagents for cancer therapyHans J Stauss, Michela Cesco-Gaspere, Sharyn Thomas, et al.
European Journal of Haematology|December 11, 2024
The Effect of the Pre-Transplant Disease Status on the Outcome for Recipients of T-Cell Depleted Allogeneic Haematopoietic Stem Cell Transplants for Large B Cell LymphomasMaria A V Marzolini, Irfan Kayani, Ben Carpenter, et al.
British Journal of Haematology|March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningWilliam M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Journal of Clinical Immunology|August 6, 2016
X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous HepatitisCathal L Steele, Matthew Doré, Sandra Ammann, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2021
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiencyLinlin Yang, Claire Booth, Carsten Speckmann, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphomaKirsty J Thomson, Emma C Morris, Don Milligan, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Immunology|June 14, 2023
Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with LymphomaEkaterina Minskaia, Jesmeen Maimaris, Persephone Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphomaKarl S Peggs, Irfan Kayani, Noha Edwards, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activityKarl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 20, 2007
Monoclonal T-cell receptors: new reagents for cancer therapyHans J Stauss, Michela Cesco-Gaspere, Sharyn Thomas, et al.
European Journal of Haematology|December 11, 2024
The Effect of the Pre-Transplant Disease Status on the Outcome for Recipients of T-Cell Depleted Allogeneic Haematopoietic Stem Cell Transplants for Large B Cell LymphomasMaria A V Marzolini, Irfan Kayani, Ben Carpenter, et al.
British Journal of Haematology|March 19, 2013
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioningWilliam M Townsend, Ailsa Holroyd, Rachel Pearce, et al.
Journal of Clinical Immunology|August 6, 2016
X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous HepatitisCathal L Steele, Matthew Doré, Sandra Ammann, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2021
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiencyLinlin Yang, Claire Booth, Carsten Speckmann, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphomaKirsty J Thomson, Emma C Morris, Don Milligan, et al.
Pageof 8